BIOGRAPHY

Professor Johann de Bono was born in Malta and studied medicine and medical oncology at the University of Glasgow. He graduated from medical school in 1989 and became a Member of the Royal College of Physicians (MRCP) in 1992. He was awarded a four-year Cancer Research Campaign Clinical Fellowship, during which he completed his PhD between 1993 and 1997.

He subsequently pursued research on clinical trial design at the Fred Hutchinson Cancer Centre in Seattle, USA, before developing novel anticancer drugs at the Institute for Drug Development at the University of Texas Health Science Centre in San Antonio between 2000 and 2003.

Professor de Bono is Regius Professor of Cancer Research at the Institute of Cancer Research (ICR) and The Royal Marsden Hospital, where he serves as Head of the Division of Clinical Studies and Director of the Drug Development Unit.

He is a world leader in prostate cancer research, having transformed the treatment of the disease through landmark clinical trials of abiraterone, cabazitaxel, enzalutamide, olaparib, and Lutetium PSMA. He has published more than 500 manuscripts, including multiple papers in the New England Journal of Medicine and The Lancet.

Among his many honours, he received the prestigious ESMO Award in 2012 and was elected a Fellow of the Royal College of Physicians in 2003.